A fundamental question in addiction biology is why opiate alkaloid drugs such as morphine and heroin have a high liability for inducing tolerance and addiction while endorphins and enkephalins, the native peptide ligands for opioid receptors do not. Following activation by agonists, opioid receptors are regulated by multiple mechanisms. Of these regulatory mechanisms, rapid endocytosis of opioid receptors is of particular interest because it is differentially regulated by peptide agonists and alkaloid drugs. Specifically, endogenous opioid peptides and certain opiate drugs such as etorphine and methadone stimulate the rapid internalization of mu opioid receptors. Morphine however, strongly activates receptor signaling but fails to stimulate the rapid internalization of mu opioid receptors. Furthermore, following endocytosis, individual receptors can be sorted differentially between recycling endosomes and lysosomes. This sorting mechanism can contribute to receptor regulation in two ways that have opposing effects on cell signaling. First, endocytosis can serve as a mechanism for receptor resensitization by delivering internalized receptors to endosomes from where they are recycled to the plasma membrane in a fully active state. Second, rapid internalization can serve as a first step toward receptor downregulation by delivering the receptors to endosomes from which they are sent to lysosomes for degradation. Most membrane proteins are rapidly recycled, presumably by default, because membrane itself is recycled continuously. Therefore it is likely that membrane receptors that are rapidly degraded following their endocytosis do so through a specific targeting mechanism. The post-endocytic sorting of individual receptors between recycling and degradative fates is biochemically specific and appears to be highly regulated, identifying this sorting step as a fundamental mechanism that controls the degradative down-regulation of a large number of receptors relevant to neuropsychiatric research. Hence for each receptor/ligand pair, one must evaluate both the endocytic and post-endocytic properties.
The specific aims outlined below are designed to elucidate the molecular basis for endocytosis and sorting of the opioid receptors and assess in a cell culture model what effects altered trafficking has on the development of tolerance and withdrawal.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA015232-04
Application #
7071768
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Lin, Geraline
Project Start
2003-07-20
Project End
2008-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
4
Fiscal Year
2006
Total Cost
$276,324
Indirect Cost
Name
Ernest Gallo Clinic and Research Center
Department
Type
DUNS #
173995366
City
Emeryville
State
CA
Country
United States
Zip Code
94608
Johnson, Tyler A; Milan-Lobo, Laura; Che, Tao et al. (2017) Identification of the First Marine-Derived Opioid Receptor ""Balanced"" Agonist with a Signaling Profile That Resembles the Endorphins. ACS Chem Neurosci 8:473-485
Milan-Lobo, Laura; Enquist, Johan; van Rijn, Richard M et al. (2013) Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism. PLoS One 8:e58362
van Rijn, Richard M; Harvey, Jessica H; Brissett, Daniela I et al. (2013) Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling. J Pharmacol Exp Ther 344:179-88
Harvey, Jessica H; van Rijn, Richard M; Whistler, Jennifer L (2013) A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers. Methods Mol Biol 995:43-54
van Rijn, Richard M; Defriel, Julia N; Whistler, Jennifer L (2013) Pharmacological traits of delta opioid receptors: pitfalls or opportunities? Psychopharmacology (Berl) 228:1-18
Whistler, Jennifer L (2012) Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:189-204
van Rijn, Richard M; Brissett, Daniela I; Whistler, Jennifer L (2012) Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists. Drug Alcohol Depend 122:156-9
Brissett, D I; Whistler, J L; van Rijn, R M (2012) Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes. Eur J Pain 16:327-37
van Rijn, Richard M; Brissett, Daniela I; Whistler, Jennifer L (2012) Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry 71:232-8
Enquist, Johan; Kim, Joseph A; Bartlett, Selena et al. (2011) A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance. J Pharmacol Exp Ther 338:633-40

Showing the most recent 10 out of 28 publications